Clasificación en acciones
#35289
IMV Inc. is a clinical-stage biotechnology company dedicated to the development... IMV Inc. is a clinical-stage biotechnology company dedicated to the development of innovative immunotherapies. The company utilizes its proprietary DPX immune-educating technology platform to create a portfolio of treatments for various solid and hematological cancers. Its leading investigational drug, maveropepimut-S, is a DPX-based immunotherapy designed to target cancer cells that express survivin. Maveropepimut-S is currently undergoing Phase II clinical trials for diffuse large B-cell lymphoma, ovarian cancer, and specific bladder, liver, and microsatellite instability-high tumors, with Phase I trials also active for breast cancer. Beyond its primary candidate, IMV is also advancing DPX-SurMAGE, which is in Phase I clinical trials for bladder cancer, and is developing DPX-COVID-19 and DPX-RSV to address infectious diseases. Originally founded in 2000 as Immunovaccine Inc., the company adopted the name IMV Inc. in May 2018 and operates from its headquarters in Dartmouth, Canada.
Precio por acción
$0.82959892
Última sincronización: 2023-05-23
Capitalización bursátil
$4.16M
Precio IMV con Capital del mercado a B
Capitalización de mercado de IMV Inc.(IMV)
Capitalización bursátil: $4.16M
A fecha de August 2026, IMV Inc. tiene una capitalización de mercado de $4.16M. Esto convierte a IMV Inc. en la 35289th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de IMV Inc. desde 2012 hasta 2026
IMV en comparación con los más populares 5 títulos stocks
| Precio por IMV |
|
Activo B |
Capital del mercado en B |
Resultados |
|
|
|
|
$5.452T
|
+131,076,102.29%
|
|
|
|
|
$4.490T
|
+107,950,940.04%
|
|
|
|
|
$4.162T
|
+100,074,320.56%
|
|
|
|
|
$3.676T
|
+88,388,142.13%
|
|
|
|
|
$2.833T
|
+68,113,157.05%
|
